Literature DB >> 14976404

Differential alterations of receptor densities of three muscarinic acetylcholine receptor subtypes and current densities of the corresponding K+ channels in canine atria with atrial fibrillation induced by experimental congestive heart failure.

Hong Shi1, Huizhen Wang, Danshi Li, Stanley Nattel, Zhiguo Wang.   

Abstract

Parasympathetic tone and congestive heart failure (CHF) are two of promoting factors in initiation and perpetuation of atrial fibrillation (AF). Recent studies indicate co-existence of multiple muscarinic acetylcholine receptor subtypes (mAChRs) that mediate several distinct K+ currents in the heart; inward rectifier K+ current IKACh by the M2, and two delayed rectifier K+ currents IKM3 and IK4AP by the M3 and M4 receptors, respectively. We studied the alterations of atrial mAChRs and their coupled K+ channels in the setting of AF in dogs with ventricular tachypacing-induced CHF. Whole-patch-clamp recordings showed that the current densities of IKACh (induced by 1 mM acetylcholine) and IK4AP (induced by 1 mM 4-aminopyridine) were ñ45% and ñ55% lower, respectively, while that of IKM3 (induced by 10 mM choline) was ñ75% higher, at a plateau voltage of 0 mV in atrial myocytes from CHF than those from healthy hearts. In healthy hearts, IKACh comprised >60%, and IKM3 and IK4AP <30%, of the total outward K+ currents mediated by mAChRs at depolarized potentials (between -20 mV and +50 mV). In AF atria of CHF dogs, however, the contribution of IKM3 increased to approximately 50%, exceeding those of IKACh or IK4AP. Western blot analyses with atrial membrane protein samples indicated that receptor densities of the M2 and M4 subtypes decreased by approximately 33% and approximately 22%, respectively, whereas that of the M3 subtype increased by approximately 2.3 folds, in parallel to the alterations of the corresponding K+ currents. We conclude that differential alterations of mAChR subtypes underlie differential alterations of their coupled K+ channels in AF atria and these differential alterations may contribute to atrial remodeling in AF induced in the setting of CHF. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14976404     DOI: 10.1159/000076924

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  14 in total

Review 1.  Functional M3 muscarinic acetylcholine receptors in mammalian hearts.

Authors:  Zhiguo Wang; Hong Shi; Huizhen Wang
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

2.  Muscarinic type-1 receptors contribute to IK,ACh in human atrial cardiomyocytes and are upregulated in patients with chronic atrial fibrillation.

Authors:  Jordi Heijman; Dorit Kirchner; Franziska Kunze; Eva Maria Chrétien; Martina B Michel-Reher; Niels Voigt; Michael Knaut; Martin C Michel; Ursula Ravens; Dobromir Dobrev
Journal:  Int J Cardiol       Date:  2017-12-22       Impact factor: 4.164

Review 3.  Altered Excitation-Contraction Coupling in Human Chronic Atrial Fibrillation.

Authors:  Eleonora Grandi; Antony J Workman; Sandeep V Pandit
Journal:  J Atr Fibrillation       Date:  2012-04-14

4.  Overexpression of M₃ muscarinic receptor is a novel strategy for preventing sudden cardiac death in transgenic mice.

Authors:  Yan Liu; Lihua Sun; Zhenwei Pan; Yunlong Bai; Ning Wang; Jinlong Zhao; Chaoqian Xu; Zhi Li; Baoxin Li; Zhimin Du; Yanjie Lu; Xu Gao; Baofeng Yang
Journal:  Mol Med       Date:  2011-07-13       Impact factor: 6.354

Review 5.  More types than one: multiple muscarinic receptor coupled K+ currents undergo remodelling in an experimental model of atrial fibrillation.

Authors:  A F James; J C Hancox
Journal:  Br J Pharmacol       Date:  2007-09-10       Impact factor: 8.739

6.  Atrial tachycardia induces remodelling of muscarinic receptors and their coupled potassium currents in canine left atrial and pulmonary vein cardiomyocytes.

Authors:  Y-H Yeh; X Qi; A Shiroshita-Takeshita; J Liu; A Maguy; D Chartier; T Hebert; Z Wang; S Nattel
Journal:  Br J Pharmacol       Date:  2007-07-09       Impact factor: 8.739

7.  Choline inhibits angiotensin II-induced cardiac hypertrophy by intracellular calcium signal and p38 MAPK pathway.

Authors:  Shu Wang; Hong-mei Han; Zhen-wei Pan; Peng-zhou Hang; Li-hua Sun; Ya-nan Jiang; Hao-xin Song; Zhi-min Du; Yan Liu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-05-09       Impact factor: 3.000

Review 8.  Muscarinic Stimulation Facilitates Sarcoplasmic Reticulum Ca Release by Modulating Ryanodine Receptor 2 Phosphorylation Through Protein Kinase G and Ca/Calmodulin-Dependent Protein Kinase II.

Authors:  Hsiang-Ting Ho; Andriy E Belevych; Bin Liu; Ingrid M Bonilla; Przemysław B Radwański; Igor V Kubasov; Héctor H Valdivia; Karsten Schober; Cynthia A Carnes; Sándor Györke
Journal:  Hypertension       Date:  2016-09-19       Impact factor: 10.190

9.  Matrine inhibits pacing induced atrial fibrillation by modulating I(KM3) and I(Ca-L).

Authors:  Yuhong Zhou; Wei Xu; Ruyi Han; Jiaying Zhou; Zhenwei Pan; Huo Rong; Junnan Li; Changqing Xu; Guofen Qiao; Yanjie Lu
Journal:  Int J Biol Sci       Date:  2011-12-09       Impact factor: 6.580

10.  Upregulation of M₃ muscarinic receptor inhibits cardiac hypertrophy induced by angiotensin II.

Authors:  Yan Liu; Shu Wang; Chao Wang; Haoxin Song; Hongmei Han; Pengzhou Hang; Yanan Jiang; Lanlan Wei; Rong Huo; Lihua Sun; Xu Gao; Yanjie Lu; Zhimin Du
Journal:  J Transl Med       Date:  2013-09-12       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.